IL138393A0 - Methods for inhibiting mrp1 - Google Patents

Methods for inhibiting mrp1

Info

Publication number
IL138393A0
IL138393A0 IL13839399A IL13839399A IL138393A0 IL 138393 A0 IL138393 A0 IL 138393A0 IL 13839399 A IL13839399 A IL 13839399A IL 13839399 A IL13839399 A IL 13839399A IL 138393 A0 IL138393 A0 IL 138393A0
Authority
IL
Israel
Prior art keywords
methods
inhibiting mrp1
mrp1
inhibiting
Prior art date
Application number
IL13839399A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL138393A0 publication Critical patent/IL138393A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
IL13839399A 1998-04-08 1999-04-07 Methods for inhibiting mrp1 IL138393A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8108898P 1998-04-08 1998-04-08
PCT/US1999/007615 WO1999051236A1 (en) 1998-04-08 1999-04-07 Methods for inhibiting mrp1

Publications (1)

Publication Number Publication Date
IL138393A0 true IL138393A0 (en) 2001-10-31

Family

ID=22162031

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13839399A IL138393A0 (en) 1998-04-08 1999-04-07 Methods for inhibiting mrp1

Country Status (17)

Country Link
US (1) US6221876B1 (id)
EP (1) EP1067932A4 (id)
JP (1) JP2002510632A (id)
KR (1) KR20010042481A (id)
CN (1) CN1296410A (id)
AU (1) AU3550299A (id)
BR (1) BR9909446A (id)
CA (1) CA2327452A1 (id)
EA (1) EA200001035A1 (id)
HU (1) HUP0102548A2 (id)
ID (1) ID26804A (id)
IL (1) IL138393A0 (id)
NO (1) NO20005041L (id)
PL (1) PL343320A1 (id)
SK (1) SK14992000A3 (id)
TR (1) TR200002804T2 (id)
WO (1) WO1999051236A1 (id)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2255294T3 (es) * 1998-08-07 2006-06-16 Chiron Corporation Derivados de isoxazol sustituidos como moduladores del receptor de estrogenos.
US6743794B2 (en) 1999-12-22 2004-06-01 Eli Lilly And Company Methods and compounds for inhibiting MRP1
DE60016039T2 (de) * 1999-12-22 2005-08-11 Eli Lilly And Co., Indianapolis Verfahren und verbindungen für die hemmung von mrp1
WO2001096346A1 (en) * 2000-06-14 2001-12-20 Eli Lilly And Company Tricyclic compounds as mrp1-inhibitors
US7064131B2 (en) 2001-04-09 2006-06-20 Eli Lilly And Company Compounds and methods for inhibiting MRP1
CN1281210C (zh) * 2003-11-29 2006-10-25 胡汛 五味子乙素在制备治疗肿瘤药物中的应用
WO2005113004A2 (en) * 2004-05-14 2005-12-01 The Cleveland Clinic Founfation Small molecule inhibitors for mrp1 and other multidrug transporters

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5182290A (en) * 1991-08-27 1993-01-26 Neurogen Corporation Certain oxazoloquinolinones; a new class of GABA brain receptor ligands

Also Published As

Publication number Publication date
NO20005041D0 (no) 2000-10-06
KR20010042481A (ko) 2001-05-25
CA2327452A1 (en) 1999-10-14
JP2002510632A (ja) 2002-04-09
EP1067932A4 (en) 2001-11-14
NO20005041L (no) 2000-10-06
BR9909446A (pt) 2000-12-12
TR200002804T2 (tr) 2001-02-21
SK14992000A3 (sk) 2001-06-11
AU3550299A (en) 1999-10-25
US6221876B1 (en) 2001-04-24
CN1296410A (zh) 2001-05-23
HUP0102548A2 (hu) 2001-11-28
ID26804A (id) 2001-02-08
PL343320A1 (en) 2001-08-13
WO1999051236A1 (en) 1999-10-14
EA200001035A1 (ru) 2001-04-23
EP1067932A1 (en) 2001-01-17

Similar Documents

Publication Publication Date Title
IL138389A0 (en) Methods for inhibiting mrp1
IL138391A0 (en) Methods for inhibiting mrp1
PL343320A1 (en) Methods for inhibiting mrp1
GB9803322D0 (en) Methods
GB9801712D0 (en) Compounds
GB9814199D0 (en) Novel method
GB9806323D0 (en) Services-connections for trailer-vehicles
HU9800230V0 (en) Bandbaluster for boondary
PL327557A1 (en) Micro-agitator for emulssions
TW345033U (en) Improvement for filtering-core
TW345035U (en) Improvement for filtering-core
HU9800093V0 (en) Skate-board for field
GB9813912D0 (en) Methods
GB9824856D0 (en) Methods
GB9827407D0 (en) Methods
GB9824501D0 (en) Methods
GB9828697D0 (en) Inhibitors
GB9803416D0 (en) Inhibitors
GB9826992D0 (en) Inhibitors
GB9812227D0 (en) Novel method
GB9815876D0 (en) Novel method
GB9806710D0 (en) Novel method
GB9810576D0 (en) Novel method
GB9828087D0 (en) Novel method
GB9814157D0 (en) Novel method